glp-1 shortage news today november 2025 Pipeline Update: August - Prime Therapeutics Alarming rise in weight loss

However, these weight loss injections may have some side effects

Macconell L, Brown C, Gurney K, Han J (2012) Safety and tolerability of Exenatide twice daily in patients with type 2 diabetes: integrated analysis of 5594 patients from 19 placebo-controlled and comparator-controlled clinical trials

They can be used in patients with an estimated glomerular filtration rate over 15 mL/min/1.73 m 2

Clinical history, food timing, response to a structured diet trial and exclusion of competing diagnoses are central

GLP-1 medications dont target belly fat specifically, but they can support overall fat loss (including visceral fat) by helping appetite control and calorie adherence